NAABAK
THEA
Identification
- Active ingredient (INN)
- ACIDE N ACETYL ASPARTYL GLUTAMIQUE
- Internal code
- 17 B 100
- Country of Origin
- France
- Pharmaceutical form
- Preservative-free Eye Drops
- Prescription List
- Highly Regulated (List I)
- Packaging
- flacon de 5ml
DAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Indications
Treatment of moderate manifestations of allergic conjunctivitis and blepharoconjunctivitis.
Associated Conditions
Do not inject, swallow.
- Do not touch the eye with the tip of the vial.
- Child: no study in children under 4 years of age.
- In severe conjunctival allergies, anti-allergic drops based on N-acetyl-aspartyl-glutamic acid can be used as a relay to the initial corticosteroid treatment.
- The absence of an instilled preservative allows the use of the eye drops when wearing soft lenses.
Mechanism of Action
Pharmacotherapeutic group
OCULAR ANTI-ALLERGIC ( S = sense organ ) NAABAK 4.9 FOR CENT, collyre solution is presented in a multidose vial equipped with a filter membrane (0.2 microns) to protect the eye from microbial contamination during the period of use.
- N-acetylaspartyl glutamic acid: o inhibits the degranulation of conjunctival mucosal mastocytes that cause the release of chemical mediators of inflammation responsible for allergy, o blocks the activation of the supplement, o inhibits the synthesis of leukotrienes (RSS-A) by sensitized cells; mastocytes, complement proteins and leukotrienes play an important role in the initiation and conduct of allergic reactions and therefore the production of ocular inflammatory symptoms and signs.
In application, the N-aspartyl acid, the home-mediated dust and the like exerts a local reaction.
Adverse Effects
Brief sensations of burning or tingling can sometimes occur during instillation.
Reporting suspected adverse reactions
Reporting suspected adverse reactions after authorization of the drug is important.
It allows for continuous monitoring of the benefit/risk of the drug.
Health professionals report any suspected adverse reactions via the national reporting system: National Agency for the Safety of Drugs and Health Products (Ansm) and network of Regional Pharmacovigilance Centres.
Warnings
For external use only.
Do not use more than one acne product at a time.
Dosage & Administration
After area is wet with
Blemfree™ Cleansing Wash Concentrate has foamed, tap Blemfree™ Cleansing Spheres with fingertips and massage in small circles for 60 seconds.
Proceed to rinse step.